Fred Mao is the Senior Partner & Managing Director at Frost & Sullivan Greater China. He is responsible for Frost & Sullivan Greater China healthcare consulting service and capital market service business, including the industries of biotech technology, traditional pharmaceutical industry, medical device and healthcare service.  Fred has affluent experiences in IPO, M&A and management consulting projects and successfully worked with many multinational companies, state-owned companies and investment communities.